Back to News
Retail news

Chattem Acquires Five J&J/Pfizer OTC Brands

Chattem, Inc. has agreed pending regulatory approval to buy five OTC brands from Johnson & Johnson and Pfizer including Act, Unison, Cortizone, Kaopectate and Balmex.

The RetailWire Daily

A daily briefing with the retail news, expert perspective, and business context to bring into your next meeting.

Want to know more? Learn more

Discussion Thread0